Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
224
NCT00525213
Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2007
Completion: Aug 31, 2009